The UK pharmaceutical industry’s self-regulatory body has published its findings in a complaint brought by a health professional against a major pharmaceutical company.
The case reveals the high degree of scrutiny applied by regulators and industry watchdog groups to how drugmakers manage communications and engagement with healthcare professionals. The